98 related articles for article (PubMed ID: 17541257)
1. Effective treatment of locally advanced endocrine tumors of the pancreas with chemoradiotherapy.
Strosberg J; Hoffe S; Gardner N; Choi J; Kvols L
Neuroendocrinology; 2007; 85(4):216-20. PubMed ID: 17541257
[TBL] [Abstract][Full Text] [Related]
2. Fluorouracil, doxorubicin, and streptozocin in the treatment of patients with locally advanced and metastatic pancreatic endocrine carcinomas.
Kouvaraki MA; Ajani JA; Hoff P; Wolff R; Evans DB; Lozano R; Yao JC
J Clin Oncol; 2004 Dec; 22(23):4762-71. PubMed ID: 15570077
[TBL] [Abstract][Full Text] [Related]
3. Streptozocin-doxorubicin, streptozocin-fluorouracil or chlorozotocin in the treatment of advanced islet-cell carcinoma.
Moertel CG; Lefkopoulo M; Lipsitz S; Hahn RG; Klaassen D
N Engl J Med; 1992 Feb; 326(8):519-23. PubMed ID: 1310159
[TBL] [Abstract][Full Text] [Related]
4. Radiotherapy in the management of pancreatic neuroendocrine tumors (PNET): experience at three institutions.
Saif MW; Ove R; Ng J; Russo S
Anticancer Res; 2013 May; 33(5):2175-7. PubMed ID: 23645772
[TBL] [Abstract][Full Text] [Related]
5. Streptozocin alone compared with streptozocin plus fluorouracil in the treatment of advanced islet-cell carcinoma.
Moertel CG; Hanley JA; Johnson LA
N Engl J Med; 1980 Nov; 303(21):1189-94. PubMed ID: 6252466
[TBL] [Abstract][Full Text] [Related]
6. Clinical experience with chronomodulated infusional 5-fluorouracil chemoradiotherapy for pancreatic adenocarcinoma.
Keene KS; Rich TA; Penberthy DR; Shepard RC; Adams R; Jones RS
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):97-103. PubMed ID: 15850908
[TBL] [Abstract][Full Text] [Related]
7. Intraoperative and conformal external-beam radiation therapy with protracted 5-fluorouracil infusion in patients with locally advanced pancreatic carcinoma.
Furuse J; Kinoshita T; Kawashima M; Ishii H; Nagase M; Konishi M; Nakagohri T; Inoue K; Ogino T; Ikeda H; Maru Y; Yoshino M
Cancer; 2003 Mar; 97(5):1346-52. PubMed ID: 12599244
[TBL] [Abstract][Full Text] [Related]
8. Phase I trial evaluating the safety of bevacizumab with concurrent radiotherapy and capecitabine in locally advanced pancreatic cancer.
Crane CH; Ellis LM; Abbruzzese JL; Amos C; Xiong HQ; Ho L; Evans DB; Tamm EP; Ng C; Pisters PW; Charnsangavej C; Delclos ME; O'Reilly M; Lee JE; Wolff RA
J Clin Oncol; 2006 Mar; 24(7):1145-51. PubMed ID: 16505434
[TBL] [Abstract][Full Text] [Related]
9. A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group.
Segawa Y; Ueoka H; Kiura K; Kamei H; Tabata M; Sakae K; Hiraki Y; Kawahara S; Eguchi K; Hiraki S; Harada M
Br J Cancer; 2000 Jan; 82(1):104-11. PubMed ID: 10638975
[TBL] [Abstract][Full Text] [Related]
10. [5-FU based chemoradiotherapy for unresectable locally advanced pancreatic cancer].
Niki T; Soejima T; Yoshikawa T; Yamamoto Y; Fujii O; Ohta Y; Tsuda M; Horita K; Tsujino K; Hirohata S; Fujino Y; Nishisaki H
Gan To Kagaku Ryoho; 2009 Jan; 36(1):63-9. PubMed ID: 19151565
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of limited field radiotherapy with concurrent capecitabine in locally advanced pancreatic cancer.
Jackson AS; Jain P; Watkins GR; Whitfield GA; Green MM; Valle J; Taylor MB; Dickinson C; Price PM; Saleem A
Clin Oncol (R Coll Radiol); 2010 Sep; 22(7):570-7. PubMed ID: 20650619
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous integrated boost-intensity modulated radiation therapy with concomitant capecitabine and mitomycin C for locally advanced anal carcinoma: a phase 1 study.
Deenen MJ; Dewit L; Boot H; Beijnen JH; Schellens JH; Cats A
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):e201-7. PubMed ID: 23517808
[TBL] [Abstract][Full Text] [Related]
13. Treatment of locally unresectable carcinoma of the pancreas: comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone. Gastrointestinal Tumor Study Group.
J Natl Cancer Inst; 1988 Jul; 80(10):751-5. PubMed ID: 2898536
[TBL] [Abstract][Full Text] [Related]
14. Treatment with combined streptozotocin and liposomal doxorubicin in metastatic endocrine pancreatic tumors.
Fjallskog ML; Janson ET; Falkmer UG; Vatn MH; Oberg KE; Eriksson BK
Neuroendocrinology; 2008; 88(1):53-8. PubMed ID: 18285678
[TBL] [Abstract][Full Text] [Related]
15. The doxorubicin-streptozotocin combination for the treatment of advanced well-differentiated pancreatic endocrine carcinoma; a judicious option?
Delaunoit T; Ducreux M; Boige V; Dromain C; Sabourin JC; Duvillard P; Schlumberger M; de Baere T; Rougier P; Ruffie P; Elias D; Lasser P; Baudin E
Eur J Cancer; 2004 Mar; 40(4):515-20. PubMed ID: 14962717
[TBL] [Abstract][Full Text] [Related]
16. Phase I/II trial of hyperfractionated accelerated chemoradiotherapy for unresectable advanced pancreatic cancer.
Tsujie M; Nakamori S; Tanaka E; Nagano H; Umeshita K; Dono K; Sakon M; Inoue T; Inoue T; Monden M
Jpn J Clin Oncol; 2006 Aug; 36(8):504-10. PubMed ID: 16855011
[TBL] [Abstract][Full Text] [Related]
17. Induction chemotherapy followed by chemoradiation in locally advanced pancreatic cancer: an effective and well-tolerated treatment.
Hudson E; Hurt C; Mort D; Brewster AE; Iqbal N; Joseph G; Crosby TD; Mukherjee S
Clin Oncol (R Coll Radiol); 2010 Feb; 22(1):27-35. PubMed ID: 19896352
[TBL] [Abstract][Full Text] [Related]
18. Streptozocin/5-fluorouracil chemotherapy is associated with durable response in patients with advanced pancreatic neuroendocrine tumours.
Dilz LM; Denecke T; Steffen IG; Prasad V; von Weikersthal LF; Pape UF; Wiedenmann B; Pavel M
Eur J Cancer; 2015 Jul; 51(10):1253-62. PubMed ID: 25935542
[TBL] [Abstract][Full Text] [Related]
19. Combination chemotherapy for locally advanced pancreatic cancer: equivalence to external beam irradiation and implication for future management.
Smith FP; Stablein D; Korsmeyer S; Neefe J; Chun BK; Woolley PV; Schein PS
J Clin Oncol; 1983 Jul; 1(7):413-5. PubMed ID: 6689426
[TBL] [Abstract][Full Text] [Related]
20. First-line chemotherapy with capecitabine and temozolomide in patients with metastatic pancreatic endocrine carcinomas.
Strosberg JR; Fine RL; Choi J; Nasir A; Coppola D; Chen DT; Helm J; Kvols L
Cancer; 2011 Jan; 117(2):268-75. PubMed ID: 20824724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
